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The Rockefeller University 2015 
ING4 belongs to a family of proteins that have been implicated in tumor 
suppression and has been linked to the activation of p53 target genes in a p53-
dependent manner. However the mechanism by which it interacts with p53 to 
activate transcription from these genes is unclear. In this study I use in vitro 
reconstitutions of cellular processes to biochemically dissect the activity of the 
ING4 complex, complementing the cell based assays that give a more 
physiological but less defined window into ING4’s effect on p53 transcriptional 
activity. Purification of the ING4 complex allowed verification of previously known 
subunits and identification of BRPF1/2/3 as a core ING4 component. 
Reconstitution of the ING4 complex allowed the identification of two distinct 
variants of the ING4 complex which utilized either JADE or BRPF as the central 
scaffold subunit. Both these variants were required to recapitulate the histone 
acetyltransferase activity of the endogenous complex. Using these complexes, I 
demonstrate that the ING4 complex histone modifying activity is not directly 
affected by p53 but is rather indirectly modulated through p53-dependent p300 
activity and enhanced by the presence of the p53-dependent trimethylated H3K4 
histone mark. I also establish an ING4 complex-mediated p53-dependent 
transcription system on chromatin templates and show that the ING4 complex 
has a direct effect on p53 dependent transcription. Additionally, the same 
conditions that enhance ING4 complex histone acetylation, namely p300 and 
trimethylated H3K4, also enhance the ING4 complex’ effects on p53 dependent 
transcription. Taken together, these results establish ING4 as a transcriptional 
coactivator of p53 and suggest two mechanisms by which p53 affects ING4 
complex histone modification and transcriptional activity. 
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1.1 Histone modifications and transcription 
The question of how the same genetic code can carry out such disparate 
activities such as differentiation, development and homeostasis is one that is of 
great interest. There is no difference in the genetic blueprint between a nerve 
cell, a liver cell, a muscle cell, or a skin cell, yet in accordance with their function, 
these cells demonstrate great phenotypic differences. The same phenomenon 
can also be observed temporally within the same cell where different reactions 
occur in response to different stimuli despite the same genome being present 
throughout. A major key to this dichotomy is through the differential expression of 
genes (Roeder, 2003). The mechanism by which gene expression is regulated is 
thus of great interest in understanding how a cell functions and in understanding 
and treating a variety of diseases that have their root cause in the misregulation 
of gene expression (Bhatia & Kleinjan, 2014). 
 
 There are many different mechanisms by which the transcriptional 
activation of genes may be regulated. These range from those that function at 
the level of DNA, such as sequence specific DNA binding transcription factors 
that recruit RNA polymerases and other transcriptional machinery, to those that 
function at the level of chromatin, such as the chromatin structure itself which 
affects different conformations to either repress or allow transcription (Roeder, 
2005). The numerous post-translational modifications on histone proteins in 
chromatin such as acetylation, methylation, phosphorylation and ubiquitination 
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have been proposed to form a histone code that exists alongside the genetic 
code and allows for an additional level of transcriptional regulation (Strahl & Allis, 
2000). More specifically, histone acetylation has been highly correlated with 
transcriptional activation (Roth, et al., 2001; Li, et al., 2007) while H3K4 
trimethylation in particular is associated with the 5’ regions of active genes and is 
strongly correlated with histone acetylation and transcription (Ruthenburg, et al., 
2007a). However the precise mechanisms behind the establishment of these 
marks and their effect on transcription have not been fully elucidated. 
 
1.2 The transcription factor p53 
 p53 is a classical transcriptional activator that binds to response elements 
contained within p53 target genes. As a tumor suppressor, it modulates the 
cellular response to a wide array of stresses (Levine, et al., 2006) and mediates 
the transcriptional activation of numerous target genes, amongst them those that 
activate the cell cycle arrest and apoptosis pathways, such as p21 and BAX 
(Laptenko & Prives, 2006). As such, it is frequently found to be mutated or 
otherwise downregulated in a variety of cancers (Levine, et al., 2006).  
 
While p53 itself has no intrinsic histone modifying capability, many p53 
cofactors are capable of post-translational protein modification and have had 
these capabilities linked to their role as cofactors of p53-mediated transcription. 
The p53 cofactor p300, for example, is capable of acetylating chromatin in a p53-
4 
dependent manner, and this acetylation is essential for p300 mediation of p53-
dependent transcription (Espinosa & Emerson, 2001; An, et al., 2004). 
Methyltransferases such as SET1 and MLL have also been shown to affect 
transcription via methylation of H3K4 (Dou, et al., 2005; Jiang, et al., 2013; Tang, 
et al., 2013), a modification that is also affected by RAD6 ubiquitylation of H2B 
(Kim, et al., 2009). One pathway by which p53 regulates the transcription of its 
target genes is therefore through modification of histones via the activity of its 
cofactors. 
1.3 Inhibitor of Growth (ING) proteins 
1.3.1 Discovery of ING proteins 
The Inhibitor of Growth (ING) family of proteins are a homologous group of 
proteins that when ectopically expressed in cells, as their name suggests, inhibit 
the growth of cells. The founding member, ING1, was first identified from a 
genetic suppressor element isolated in a subtractive hybridization assay that 
compared normal mammary epithelium and several breast cancer cell lines. A 
screen for genetic elements that were differentially expressed in the cancer cell 
lines and had an effect on cell growth resulted in the identification of ING1 
(Garkavtsev, et al., 1996). Four other members of the ING family (INGs 2-5) were 
subsequently identified via sequence homology and characterized as having 
several similar structural features, foremost of which is a highly conserved PHD 
finger (Fig 1A & 1B) (Coles & Jones, 2009). All members were also found to have 
5 
Fig 1. The Inhibitor of Growth family of proteins. 
A) Structural motifs of the ING family of proteins. PIP – PCNA interacting protein
motif. PBD – Partial bromodomain. LZL – Leucine zipper-like region. NCR – 
Novel conserved region. NLS – Nuclear localization sequence. PHD – Plant 
homeodomain. PBR – Poly basic region. 
B) Sequence alignment of ING family proteins showing the highly conserved
PHD finger domain in yellow. 
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Fig 1B 
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Table 1. ING complex members. 
9 
the same inhibitory effect on cell growth (Shimada, et al., 1998; Nagashima, et 
al., 2001; Gunduz, et al., 2002; Nagashima, et al., 2003; Shiseki, et al., 2003). 
1.3.2 Characteristics of ING proteins 
In addition to their sequence homology and their ability to inhibit cell 
growth when expressed, all ING proteins have several characteristics in 
common. Each is a member of a multisubunit protein complex that possesses a 
histone modifying capability- histone deacetylase in the case of ING1 and ING2, 
and histone acetyltransferase in the case of INGs 3, 4 and 5 (Table 1) (Skowyra, 
et al., 2001; Kuzmichev, et al., 2002; Doyon, et al., 2004; Doyon, et al., 2006). 
Secondly, each possesses a conserved Plant Homeodomain zinc-finger (PHD 
finger) that has been shown in several proteins to recognize and bind 
preferentially to trimethylated, and to a lesser extent dimethylated, H3K4 (Shi, et 
al., 2006; Li, et al., 2006; Wysocka, et al., 2006). In the case of ING4, this is 
accomplished via an aromatic cage that interacts with the trimethylammonium 
group of H3K4 (Pena, et al., 2006). This ability to discriminate between 
trimethylated H3K4 and the other methylation states of H3K4 identifies the ING 
proteins as ‘readers’ of the histone code. In conjunction with the catalytic ability 
associated with their complexes, the ING proteins thus provide an effector 
pathway by which the H3K4 trimethylation mark might be translated into some 
downstream activity (Ruthenburg, et al., 2007a). 
10 
1.3.3 Association with p53 
The ING protein family as a whole has also been implicated in the 
regulation of several p53-activated pathways. The ING-mediated inhibitory 
effects on cell growth were dependent on p53 in the majority of cases and a 
synergistic inhibitory effect on cell growth was observed with several of the ING 
proteins when they were co-expressed with p53. Additionally, all ING proteins, 
with the exception of ING3, have been shown to co-immunoprecipitate with p53. 
ING proteins thus show a physical and functional interaction with p53 (Coles & 
Jones, 2009). Altogether these observations suggest that the ING proteins might 
play a role as p53 cofactors. 
1.4 The ING4 protein 
1.4.1 Characteristics of the ING4 protein 
The fourth member of the ING family, ING4, is of particular interest 
because the complex it exists in includes a histone acetyltransferase (Doyon, et 
al., 2006). This, together with its H3K4 trimethyl recognizing PHD finger, raises 
the possibility of cross-talk between trimethylated H3K4me3 and histone 
acetylation. Additionally, the ING4 protein complex consists of a limited number 
of subunits, which makes complete reconstitution of the complex a more 
tractable problem. Finally, unlike the ING5 complex, the ING4 complex is thought 
to be primarily involved in transcription regulation, rather than both transcription 
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and DNA replication (Doyon, et al., 2006). For these reasons the decision was 
made to focus this study on the fourth member of the ING family of proteins. 
 
ING4 is frequently found to be downregulated in cancers and its 
expression has been inversely correlated with cancer progression and severity 
(Piche & Li, 2010). As with other members of the ING family, ING4 has been 
implicated in p53 mediated gene expression and DNA damage responses. More 
specifically, ING4 coimmunoprecipitates with p53 and ectopic expression of ING4 
has been shown to result in reduced colony formation, cell cycle arrest and 
apoptosis. Activation of the p21 and BAX promoters and expression of 
endogenous p21 and BAX were also induced by ectopic ING4 expression in a 
p53-dependent manner (Shiseki, et al., 2003; Zhang, et al., 2004; Doyon, et al., 
2006; Avvakumov, et al., 2012). These observations suggest that ING4 can 
function as a transcriptional coactivator of p53 in the regulation of these 
pathways. 
 
However, two other studies concluded that overexpression of ING4 also 
conferred inhibitory effects in the p53 mutated T47D and U-118MG cell lines 
(Kim, et al., 2004; Unoki, et al., 2006). Additionally, ING4 has also been 
associated with the transcription factors NF-κB and HIF-1α. This suggests that 
ING4 has additional functions independent of p53, possibly as a cofactor to other 
transcription factors. However the mechanism by which it functions as a cofactor 
12 
 
in these other cases is unlikely to be the same since in these cases it seems to 
function as a negative cofactor, repressing the functions of both NF-κB and HIF-
1α (Garkavtsev, et al., 2004; Ozer, et al., 2005), rather than as a positive factor, 
as in the case of p53 and the activation of p21 and BAX. 
 
With respect to ING4’s occupancy on genes, ectopically expressed ING4 
was found to be enriched around the transcription start sites (TSS) of DNA 
damage activated promoters in response to doxorubicin treatment. This 
correlates with the pattern of enrichment of trimethylated H3K4 and is dependent 
on the trimethylated H3K4 recognizing ING4 PHD finger. This suggests that the 
PHD-trimethylated H3K4 interaction is important for the recruitment of ING4 to 
such promoters (Hung, et al., 2009) and further supports the role of ING4 as a 
transcriptional cofactor. 
 
1.4.2 Structure of the ING4 protein 
ING4 is a ~29kDa protein 249 amino acids in length (Fig 2A). It contains 
an N-terminal leucine zipper-like (LZL) region, a unique region that is conserved 
amongst the INGs termed the novel conserved region (NCR), a C-terminal plant 
homeodomain (PHD) zinc finger and two nuclear localization signals (NLS). The 
LZL region is thought to mediate dimerization between two ING4 molecules and 
potentially between ING4 and ING5 molecules (Palacios, et al., 2010; Culurgioni, 
et al., 2012). The ING4 PHD finger, as with all other ING PHD fingers, has been  
13 
Fig 2. The ING4 complex. 
A) Domain structure of the ING4 complex subunits. PHD – Plant homeodomain
finger. Bromo – bromodomain. PWWP – Pro-Trp-Trp-Pro motif. S – Serine rich 
region. ZF – Zinc finger. MYST – histone acetyltransferase domain. LZL – 
Leucine zipper like region. NCR – Novel conserved region. NLS – Nuclear 
localization signal. LZ – Leucine zipper. 
B) Schematic representation of the JADE1S-HBO1 complex and the JADE1L-
HBO1-ING4-hEAF6 complex. 
14 
Fig 2A 
Fig 2B 
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shown to bind specifically to histone trimethylated H3K4 (Shi, et al., 2006; 
Palacios, et al., 2008; Hung, et al., 2009), while the first NLS (NLS1) is thought to 
play a role in the ING4-p53 interaction (Zhang, et al., 2005). However, another 
study failed to find any significant p53 interaction (Palacios, et al., 2010). The 
PHD domain, the NCR and the first NLS are conserved amongst all the INGs, 
while the LZL region is absent from ING1 and the second C-terminal NLS is 
present only in ING 4 and 5 (Coles & Jones, 2009).  
 
In addition to the full length ING4, multiple splice variants of the ING4 
transcript have been detected. The ING4 proteins that were expressed from 
three of these variants had a missing or truncated NLS1 and were shown to 
localize predominantly to the cytoplasm instead of the nucleus (Unoki, et al., 
2006). However, other variants that also modified NLS1 did not affect the nuclear 
localization, but rather affected the localization of ING4 within the nucleus (Tsai, 
et al., 2008). Curiously, the presence of the second C-terminal NLS (NLS2) 
appeared to be dispensable for nuclear localization, suggesting a non-functional 
NLS (Unoki, et al., 2006). Three more variants that included either an intact or 
slightly shorter NLS1 were also shown to localize to the nucleus and to maintain 
their interaction to p53 and HBO1 (Raho, et al., 2007). While the existence of 
these naturally occurring alternatively spliced proteins has yet to be detected, 
these studies do suggest that the NLS1 is responsible for the nuclear localization 
of ING4. 
16 
1.5. The ING4 Complex 
1.5.1 Components of the ING4 complex 
The ING4 complex consists of ING4 itself and three additional proteins: 1) 
the MYST family histone acetyltransferase HBO1 (histone acetyltransferase 
binding to ORC1), 2) a member of the JADE (gene for apoptosis and 
differentiation in epithelia) protein family, JADE1L/2/3, and 3) the uncharacterized 
protein hEaf6 (Fig 2A), which is also present in the ING3-Tip60 complex, the 
ING5-HBO1 complex, and the ING5-MOZ/MORF complex (Fig 1B) (Doyon, et 
al., 2006). Additional interactions have also been identified with other proteins 
such as NF-κB and p300 (Garkavtsev, et al., 2004; Shiseki, et al., 2003), but 
these are lost when the ING4 complex is more stringently purified and are not 
thought to be integral components of the ING4 complex (Doyon, et al., 2006). 
1.5.1.1 HBO1 
HBO1 is a MYST family histone acetyltransferase that has been 
implicated in DNA replication as well as transcription (Burke, et al., 2001; Iizuka, 
et al., 2006; Georgiakaki, et al., 2006; Miotto & Struhl, 2006). It is a member of 
both ING4 and ING5 complexes (Doyon, et al., 2006) and has been shown to 
interact with p53 (Iizuka, et al., 2008). HBO1 is thought to be responsible for 
significant proportion of histone H4 acetylation in the cell at lysine residues 5, 8 
and 12, but not 16, in 293 cells (Doyon, et al., 2006) and for H3K14 acetylation in 
17 
 
mouse primary embryonic fibroblasts and erythroblasts (Kueh, et al., 2011; 
Mishima, et al., 2011).  
  
 1.5.1.2 JADE 
Of the JADE protein members of the complex, the JADE1 homolog has 
been the most extensively studied. JADE1 exists as two isoforms – a full length 
protein of 842 amino acids termed JADE1L, and a truncated version of 509 
amino acids termed JADE1 or JADE1S. The full length JADE1L isoform is 
associated with the full ING4 complex while the truncated JADE1S isoform is 
associated only with HBO1, forming a smaller JADE1S-HBO1 complex that lacks 
ING4 and hEaf6 (Fig 2B). Both JADE1 isoforms possess two PHD domains, the 
first of which, PHD1, binds preferentially to unmethylated H3K4 and 
demonstrates a slight preference for trimethylated H3K36. The second PHD 
domain, PHD2, binds independently of H3K4 methylation status and is thought to 
be essential for both the JADE1S complex and the larger JADE1L/2/3-ING4 
complex’ association with chromatin. It is also thought to be necessary for 
JADE1L’s inhibitory effects on cell growth (Foy, et al., 2008; Saksouk, et al., 
2009).  
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1.5.1.3 BRPF 
More recently, BRPF1/2/3, which was previously identified as a member of 
the ING5 complex, has been identified as an ING4 associated protein (Mishima, 
et al., 2011). However, the precise relationship of BRPF1/2/3 to ING4 and to the 
other ING4 subunits has yet to be fully elucidated. All BRPF paralogs have 2 
PHD fingers, with the PHD fingers of BRPF2 (which is more commonly known as 
BRD1), being the most extensively studied. Similar to the JADE PHD fingers, the 
first BRD1 PHD finger binds preferentially to unmethylated H3K4 while the 
second PHD finger seems to interact with H3 independent of H3K4 methylation 
(Qin, et al., 2011; Lalonde, et al., 2013) and has also been shown to be capable 
of binding nonspecifically to DNA (Liu, et al., 2012). Based on conservation of 
key residues, it is possible that this is also a property of the JADE PHD2 
domains, although this has not been shown. Additionally, all BRPF proteins 
possess a bromodomain that binds acetyl-lysines (Sanchez & Zhou, 2009), and a 
PWWP domain, that has an affinity for trimethylated H3K36 (Vezzoli, et al., 
2010). 
 
1.5.2 Trimethylated H3K4-dependent acetylation 
 Through its subunits, the ING4 complex possesses multiple chromatin 
readers (Table 2). These readers, combined with the histone acetylating HBO1 
suggests that the ING4 complex as a whole could function as an effector,   
19 
Table 2. Chromatin binding domains of the ING4 complex. 
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mediating its histone acetylation activity in response to one or more of these 
marks. Indeed, similar to what has been observed with the orthologous yeast 
NuA3 complex (Taverna, et al., 2006), ING4 complex mediated increase in H3 
acetylation in response to trimethylated H3K4 has been demonstrated on H3 
peptides and reconstituted nucleosomes (Hung, et al., 2009). A similar increase 
was also shown with the homologous ING5 complex on oligonucleosomes 
purified from yeast (Saksouk, et al., 2009). There is thus an ING4 complex-
mediated link between trimethylated H3K4 and H3 acetylation (Fig 3), and 
through this histone acetylation, between trimethylated H3K4 and transcriptional 
activation. 
  
21 
Fig 3. ING4 complex mediates H3K4me3-dependent H3 acetylation 
The ING4 complex HBO1 subunit acetylates H4 independent of H3K4 
methylation status. Recognition of H3K4me3 by the ING4 PHD finger mediates 
H3 acetylation in addition to the H3K4me3 independent H4 acetylation. Blue 
arrows represent histone acetylation activity by the HBO1 subunit of the ING4 
complex and point to the resulting histone acetylation. The black arrow 
represents the interaction between the ING4 PHD finger and H3K4me3. H3ac: 
Acetylation on H3. H4ac: Acetylation on H4. H3K4me3: Trimethylated H3K4 
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Chapter 2 
 
Composition and Structure of the 
ING4 complex 
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2.1 Preface 
 The ING4 complex was first purified by Doyon et al via TAP-tag ING4 
purification and was determined to be composed of the subunits JADE1L/2/3, 
HBO1, ING4 itself, and hEAF6 (Fig 1B) (Doyon, et al., 2006). Other studies have 
looked at the interactions between the various subunits within the ING4 and 
homologous ING5 complexes, using co-immunoprecipitation of ectopically 
expressed proteins and in vitro binding of recombinant proteins (Foy, et al., 2008; 
Saksouk, et al., 2009; Avvakumov, et al., 2012; Lalonde, et al., 2013). These 
studies showed that there is a JADE1-HBO1 interaction, and that additional 
interactions with ING4 and hEAF6 are mediated through the C-terminal of 
JADE1L that is absent in the shorter JADE1S isoform (Fig 4A). This arrangement 
is similar to that of the ING5-BRPF complex, where the central BRPF is 
responsible for bridging the catalytic MOZ/MORF and ING5/hEAF6 (Fig 4B) 
(Ullah, et al., 2008).  
 
A subsequent BRD1 (BRPF2) immunoprecipitation by Mishima et al 
showed the existence of a BRD1 containing ING4-HBO1 complex (Mishima, et 
al., 2011) that was undetected in the original purification (Doyon, et al., 2006). 
The association with ING4 and HBO1 was subsequently also shown to occur 
with the BRPF1 and BRPF3 paralogs (Lalonde, et al., 2013). Together these 
results suggest the existence of an ING4 complex that can include a BRPF 
subunit. 
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Fig 4. Interactions between ING4 and ING5 complex subunits. 
A) Interactions between the subunits of the JADE1S complex and the JADE1L-
ING4 complex. The shorter JADE1S protein is unable to interact with ING4 and 
hEAF6. 
B) Interactions between the subunits of BRPF-ING5 complex.
Arrows represent protein interactions. Crossed out arrows represent interactions 
that are no longer possible for the JADE1S protein. 
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However many of the assays used in these studies relied upon 
overexpression of all subunits of interest in human 293T cells, followed by 
coimmunoprecipitation and analysis by Western blots (Hung, et al., 2009; 
Saksouk, et al., 2009; Avvakumov, et al., 2012; Lalonde, et al., 2013). While this 
approach allows for identification of specific proteins that are present in the 
immunoprecipitate, is inherently biased as the only proteins that will be identified 
are the proteins that are blotted for. It does not allow the conclusion that these 
identified proteins directly interact with each other - other yet to be identified 
proteins in the immunoprecipitate could be responsible for mediating the 
interactions of the identified proteins. 
 
Additionally, as noted in the original ING4 complex purification, 
overexpression of a protein can lead to non-specific (Doyon, et al., 2006), as well 
as specific interactions with endogenous contaminating proteins. This problem is 
compounded by the large number of permutations of the ING4 complex that can 
occur, with possible interactions with both JADE and BRPF (Doyon, et al., 2006; 
Mishima, et al., 2011; Lalonde, et al., 2013). Dimerization between ING4 and 
ING5 proteins (Palacios, et al., 2010; Culurgioni, et al., 2012) allow for additional 
contamination by both ING5 as well as ING5 associated proteins such as 
MOZ/MORF (Doyon, et al., 2006; Ullah, et al., 2008).  
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The precise composition of an ING4 complex reconstituted and 
characterized in this manner from 293T cells is therefore unclear. In addition to 
the desired subunits, the final immunoprecipitate could also include endogenous 
JADE, BRPF, HBO1, and hEAF6 via interactions with the ING4 subunit. If ING4 
can form heterodimers with ING5, this complex could also contain ING5 and 
ING5-associated proteins such as MOZ/MORF. A JADE-HBO1-ING4-hEAF6 
complex reconstituted in this manner could therefore also include BRPF, 
MOZ/MORF, and ING5, leading to a heterogenous mixture of complexes rather 
than a homogenous purification of JADE-HBO1-ING4-hEAF6. Caution must 
therefore be taken in any conclusions drawn regarding the complexes purified or 
reconstituted in this manner. 
 
To circumvent these risks of contamination and to obtain a better 
understanding of ING4 complex composition, we therefore set out to purify the 
ING4 complex with minimal expression of ectopic proteins. We also intended to 
reconstitute the ING4 complex in a non-mammalian system, allowing a cleaner 
analysis of protein-protein interactions without the risk of contaminating 
mammalian proteins. 
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2.2 Composition of the ING4 complex 
2.2.1 Purification of ING4 and associated proteins 
To purify the ING4 complex a HeLa Tet-on cell line (Tang, et al., 2013) 
was first established that uses doxycycline to induce expression of ectopic 
FLAG-tagged ING4 (f:ING4). Conditions were then established under which 
ectopic ING4 expressed was low – to an equivalent level as endogenous ING4 
(Fig 5A). Nuclear extract (NE) from the cells were made and the FLAG-ING4 and 
its associated proteins were subsequently purified. 
Initial attempts to purify the ING4 complex using M2-affinity purification on 
nuclear extract (Fig 5B) made from the f:ING4 cell line (Dignam, et al., 1983) 
were unsuccessful, with elution of the ‘complex’ at the final step containing little 
ING4 (Fig 5C). Analysis of ING4 levels at each step of the purification process 
identified the dialysis step during the nuclear extract procedure, where the salt 
concentration was brought down to 100mM KCl, as the point where the majority 
of the ING4 was lost (Fig 5D). Attempts to locate the missing ING4 were 
unsuccessful – treating of the pellet obtained from centrifugation extract post-
dialysis with high salt buffer did not reveal the presence of any great amount of 
ING4 (data not shown). However, this loss could be circumvented by modifying 
the dialysis step to a higher salt dialysis. A dialysis to 300mM KCl resulted in a 
low enough salt concentration for the subsequent purification step without any 
observable loss of ING4 from the nuclear extract (Fig 6A & 6B). 
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Fig 5. ING4 complex purification from low salt nuclear extract. 
A) Doxycycline induction of FLAG-tagged ING4. Doxycycline was titrated over
range of concentration from 100 to 1200ng/ml to obtain expression of ectopic 
FLAG-ING4 (upper band) approximately equivalent to endogenous ING4 (lower 
band) (indicated by arrow) (Western blot with indicated antibody) 
B) Outline of initial ING4 complex purification strategy from nuclear extract
dialysed to 100mM KCl. 
C) Silver stain of the initially purified ‘ING4 complex’ compared to a mock M2
affinity purification conducted on HeLa nuclear extract in which the ectopically 
expressed FLAG-ING4 was not expressed. 
D) ING4 in nuclear extract at high and low salt showing loss of ING4 during the
dialysis process. (Western blot with indicated antibody) 
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ING4 complex purified from the nuclear extract contained bands that 
corresponded to the molecular weights of expected proteins, but also included 
several other contaminating bands that were also present in the mock purification 
(Fig 6C). A P11 ion exchange chromatography step was therefore added to the 
purification (Fig 6D). Both ING4 and HBO1 were found to elute from the column 
with the 500mM KCl fraction (Fig 6E). This fraction was dialysed again to 300mM 
KCl and subjected to M2 affinity purification to give a purified ING4 complex 
(termed ING4C, with ‘ING4 complex’ hereafter referring to ING4 complex(es) in 
general). 
2.2.2 Verification of basic components 
The purified ING4C was analyzed by silver stain which revealed bands 
that correspond to the approximate molecular weights of JADE1L/2/3, HBO1, 
ING4 and hEAF6 (Fig 6F, slices 5, 7, 12 & 13). Western blot further verified the 
presence of ING4 and HBO1 (Fig 6G). Analysis of the purified ING4C by mass 
spectrometry conducted by the Rockefeller University Proteomics Resource 
Center confirmed the identities of JADE1L/2/3, HBO1, ING4 and hEAF6, 
suggesting that the M2 immunoprecipitation of FLAG-ING4 was successful in 
pulling down the ING4 complex. 
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Fig 6 ING4 complex purification from high salt nuclear extract. 
A) ING4 complex purification scheme from nuclear extract dialysed to 300mM
KCl. 
B) ING4 levels remain constant after high salt dialysis of nuclear extract.
(Western blot with indicated antibodies) 
C) Silver stain of the high salt purified ING4 complex compared to a mock
purification. 
D) High salt P11-M2 purification scheme of the ING4 complex.
E) Analysis of ING4 and HBO1 in the P11 eluted fractions. (Western blot of
eluted fractions denoted by number and elution buffer used with indicated 
antibodies). 
F) Silver stain of P11/M2 purified ING4 complex (ING4C). Proteins in each gel
slice (as indicated) were identified by mass spectrometry. 
G) Verification of ING4 and HBO1 in the purified ING4C compared to a mock
purification. (Western blot with indicated antibodies) 
H) Verification of MLL1 and associated proteins in ING4C. (Western blot with
indicated antibodies) 
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2.2.3 Identification of BRPF1/2/3 as an additional subunit 
In addition to bands corresponding to the proteins previously identified as 
being members of the ING4 complex, a larger band of ~150kDa was also 
observed in the silver stain (Fig 6F, slice 3). Mass spectrometry analysis 
identified this as BRPF1/2/3 (BRPF2 is also known as BRD1), proteins that were 
originally found to be members of the ING5 complex, but not the ING4 complex 
(Table 1). However other members of the ING5 complex such as MOZ, MORF 
and ING5 itself were not detected, suggesting a bona fide interaction between 
BRPF1/2/3 and the ING4 complex rather than contamination by the ING5 
complex. BRD1 was also found to be associated with ING4 by Mishima et al 
(Mishima, et al., 2011), although the complex obtained there also contained 
many other proteins such as HSP90, TR150 and hnRNPC1. In contrast, the 
more stringently purified ING4 complex obtained here does not contain these 
other proteins. This implies that BRPF1/2/3 interact more strongly with ING4 than 
do these other proteins and suggests that BRPF1/2/3 are members of the core 
ING4 complex. 
2.2.4 Association with the MLL1 complex 
The analysis by mass spectrometry identified several additional proteins 
as MLL1, ASH2L, RBBP5, and WDR5 and CCAR1 (Fig 6F). The MLL1, ASH2L, 
RBBP5 and WDR5 proteins were of interest as they comprise the core MLL1 
complex, which is capable of H3K4 methylation (Dou, et al., 2006). These 
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subunits were subsequently verified by Western blot (Fig 6H). While the 
aforementioned MLL1 subunits could be identified by mass spectrometry 
analysis and Western blot, unlike the other ING4 complex subunits they could not 
be easily matched to any of the visible bands on the silver stain (Fig 6F). This 
suggests that the MLL1 subunits are substoichiometrically associated ING4, and 
are not an integral part of the ING4 complex, but rather exist as a separate MLL1 
complex that interacts strongly with the ING4 complex. 
 
2.3 Structure of the ING4 complex 
2.3.1 JADE1L forms the central scaffolding protein for the ING4 
complex and is stabilized by HBO1 
 To better understand the arrangement of subunits within the ING4 
complex, a reconstitution of the complex was done using baculovirus to express 
the desired proteins in Sf9 cells. For the purposes of this reconstitution (to 
determine direct interactions between individual protein subunits), this system is 
advantageous to using a mammalian system due to the risk of contamination 
with the naturally interacting endogenous mammalian proteins that would be 
present in a human cell line. Additionally, the reconstituted complexes were 
analyzed by Coomassie stain, which would reveal the presence of any 
contaminating Sf9 proteins that might be present in the final purification. 
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First, the originally identified Jade1L-HBO1-ING4-hEAF6 complex (termed 
JHIE) was reconstituted by infecting Sf9 cells with baculoviruses expressing 
JADE1L, HBO1, hEAF6 and FLAG-ING4. The resulting protein complex was 
purified by M2 affinity purification and Coomassie stained. This revealed bands 
that corresponded to the expected subunits, indicating a successful reconstitution 
of the JHIE complex (Fig 7A & 7B). 
Different combinations of the baculoviruses were also used to provide 
information regarding protein-protein interactions within the complex. Omission of 
hEAF6 had minimal effects on the resulting complex. As expected, the hEAF6 
subunit was absent but the remaining JADE1L, HBO1 and FLAG-ING4 subunits 
were still present in the resulting complex at comparable levels. Omission of 
JADE1L resulted in the complete loss of HBO1 as well as JADE1L, indicating 
that HBO1’s association with the ING4 complex is through the JADE1L subunit. 
Levels of hEAF6 was also reduced but not completely absent, indicating that the 
hEAF6 subunit does bind directly to ING4, but that its presence in the complex is 
stabilized either directly or indirectly by the presence of JADE1L. 
Omission of HBO1 resulted in a significant but incomplete loss of JADE1L 
in addition to the loss of HBO1, as well as a reduction in hEAF6 similar to what 
was observed in the JADE1L omission (Fig 7C). This suggests that while HBO1 
is a peripheral subunit, whose association with the complex is through JADE1L, it 
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Fig 7. Reconstitution and purification of ING4 complex subunits. 
A) JHIE and BHIE complexes reconstituted by baculovirus expression in Sf9 cells
of JADE1L, HBO1, FLAG-tagged ING4, and hEAF6 or BRD1, HBO1, FLAG-
tagged ING4 and hEAF6 respectively. The resulting complexes were purified 
through M2-affinity purification. (Coomassie stain) 
B) Western blots of the reconstituted JHIE and BHIE complexes verifying the
identity of ING4, HBO1 and hEAF6. (Western blot with indicated antibodies) 
C) ING4 pull-downs from Sf9 cells infected with baculoviruses combinations
expressing the indicated subunits. (Coomassie stain) 
D) JADE1L and BRD1 are stabilized in the presence of HBO1. Purification of
reconstituted JADE1L, JADE1L-HBO1, BRD1 and BRD1-HBO1 through FLAG-
tagged JADE1L or FLAG-tagged BRD1. Note the increased levels of JADE1L 
and BRD1 obtained when they are coexpressed with HBO1. The BRD1 
reconstitutions were also subjected to Western blot to verify the identity of the 
degraded BRD1. (Coomassie stain and Western blot with indicated antibody) 
E) Purification of individual FLAG-ING4 and FLAG-HBO1 proteins via baculovirus
expression in Sf9 cells. (Coomassie stain) 
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does play a role in stabilizing JADE1L. This stabilization has been previously 
observed when both proteins were expressed in mammalian cells (Foy, et al., 
2008). The loss of hEAF6 could be due to a stabilizing effect by HBO1, but can 
also be interpreted as a secondary effect, since the loss of JADE1L has already 
been shown to adversely affect the integration of hEAF6 into the complex. 
 
To further verify the HBO1-JADE1L interaction and stabilization, FLAG-
JADE1L was expressed either alone, or together with HBO1, and M2 affinity 
purified (Fig 7D). As evidenced from the JADE1L-HBO1 dimer obtained, JADE1L 
is capable of directly interacting with HBO1. Additionally, even though identical 
titers of JADE1L expressing baculovirus were used in both cases, the amount of 
JADE1L that was obtained in the JADE1L-HBO1 purification was substantially 
greater than the amount of JADE1L purified alone, again supporting the 
stabilization of JADE1L by HBO1. 
 
2.3.2 BRPF2 (BRD1) is an alternative scaffold to JADE1L and is 
stabilized by HBO1 
Comparing the JADE1L-containing ING4 complex to the BRD1-containing 
ING5 complex, certain similarities can be observed. They both contain hEAF6, 
they both contain an ING protein and they both contain a MYST HAT (HBO1 in 
the case of ING4 and MOZ/MORF in the case of ING5). The BRPF subunit is 
known to function as the central scaffold for the ING5 complex, while the JADE 
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subunit has been shown to function as the central scaffold for the ING4 complex. 
Based on these similarities, it seemed possible that BRD1 might also play a 
similar role in an ING4 complex by replacing JADE as the central scaffold. 
 
The ability of BRD1 to interact directly with HBO1 was first established by 
expressing and purifying either FLAG-BRD1 alone or together with HBO1 (Fig 
7D). While expression of BRD1 on its own was minimal and heavily degraded, 
the addition of HBO1 resulted in increased expression and stability of BRD1 (Fig 
7D, western blot of BRD1), indicating that HBO1 has a stabilizing effect on BRD1 
similar to what is observed with JADE1L. For comparison, FLAG-HBO1 and 
FLAG-ING4 were also individually expressed and purified (Fig 7E). 
 
A BRD1-HBO1-ING4-hEAF6 complex (termed BHIE) was then 
reconstituted in the absence of any JADE (Fig 7A & 7B). The success of this 
reconstitution indicates that a BRD1-ING4 complex could exist independently of 
the JADE protein or the ING5 complex, and that BRD1 could substitute for JADE 
as the central scaffold of the ING4 complex. This further suggests that the HeLa 
purified ING4 complex, which contained both JADE1L/2/3 and BRPF1/2/3, is a 
combination of two distinct complexes – one version that utilizes JADE as its 
central unit, and another that utilizes BRPF, rather than one complex that 
contains both JADE and BRPF (Fig 8).  
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2.4 Discussion 
In agreement with previous studies, the purification of an ING4 complex 
verifies the presence of the originally identified JADE, HBO1 and hEAF6 subunits 
(Doyon, et al., 2006), as well as the subsequently identified BRPF subunits 
(Mishima, et al., 2011, Lalonde, et al., 2013). The absence of other proteins 
previously identified by Mishima et al as being associated with ING4 such as 
HSP90 or hnRNPC1, suggests that this more stringent purification contains 
proteins that are more tightly associated with ING4. Additionally, the identification 
of the MLL1 complex as a novel interacting partner of the ING4 complex 
suggests a possible functional interaction between MLL1-mediated histone 
methylation and ING4 complex activity. 
 
From the reconstitutions of JHIE and BHIE complexes, it can be 
concluded that two possible versions of the ING4 complex are possible-the 
previously identified JHIE complex and the new BHIE complex. In contrast to 
previous studies that used coimmunoprecipitation of overexpressed subunits 
from human 293T cells with detection by Western blot (Saksouk, et al., 2009; 
Lalonde, et al., 2013), the successful reconstitution of the complex in Sf9 cells in 
the absence of other mammalian subunits strongly suggests that all the 
interactions between member subunits are direct, that BRD1 is capable of 
substituting for JADE as the central scaffolding subunit, and that the BHIE 
complex is a version of the ING4 complex that can exist independently of JADE, 
MOZ/MORF or any other protein. 
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Fig 8. Schematic representations of the original JADE-ING4 and BRPF-ING5 
complexes and the proposed BRPF-ING4 complex. 
The originally identified ING4 complex consists of JADE, HBO1, ING4 and 
hEAF6. The originally identified ING5-BRPF complex consists of BRPF, 
MOZ/MORF, ING5 and hEAF6. Based on sequence homology, the presence of 
BRPF (but not MOZ/MORF or ING5) in a purified ING4 complex suggests the 
existence of a BRPF-HBO1-ING4-hEAF6 complex. 
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While much progress has been made in identifying the key members of 
the ING4 complex, as well as the various regions on the ING4 complex subunits 
that are responsible for their interactions with one another, more work remains to 
be done. The possibility of an ING4-ING4 or ING4-ING5 dimer raises the 
possibility of an ING4 complex-ING4 complex or ING4 complex-ING5 complex 
dimer (Palacios, et al., 2010), allowing for a whole array of permutations of 
scaffolding and catalytic subunits, as well as an expansion of the number of 
histone marks that can be read by such a dimer compared to a single ING4 or 
ING5 complex. However the existence of such a dimeric complex and its effect 
on chromatin has yet to be established.  
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Chapter 3 
Histone modifying activities of the 
ING4 complexes 
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3.1 Preface 
 In conjunction with ING4, HBO1 has been shown to acetylate H4 
independent of trimethylated H3K4, while recognition of trimethylated H3K4 by 
the ING4 PHD finger mediates acetylation of H3. (Saksouk, et al., 2009; Hung, et 
al., 2009). The specific acetylated histone lysine residues that the ING4 
complexes are responsible for seems dependent on the cell lines used. Its H4 
HAT activity on nucleosomes is the same in 293T and MCF cells, where a 
knockdown of HBO1 results in a global decrease of acetylation at H4K5, K8 and 
K12 but not K16 (Doyon, et al., 2006). ChIP assays have linked overexpression 
of various members of the ING4 complex to an increase in acetylation at H4K5, 
K8, and K12 residues, as well as H3K9, K14 and K23 (Saksouk, et al., 2009; 
Hung, et al., 2009; Avvakumov, et al., 2012; Mishima, et al., 2011; Lalonde, et 
al., 2013).  
 
In contrast, a knockout of HBO1 in a mouse primary embryonic fibroblast 
cell line correlated only to a decrease in acetylation at H3K14, with acetylation at 
H3K9 and H4K5 actually being increased while acetylation at H4K8 and H4K12 
were unchanged (Kueh, et al., 2011). The actual sites which HBO1 is responsible 
for acetylating may therefore vary between cell lines. Additionally, the limitation of 
cell based assays are such that while the overall effects of protein 
overexpression, knockdown or knockouts can be determined, there is no way to 
tell if this is due to a direct effect of the ING4 complex itself, or is instead 
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mediated indirectly through some other protein or protein complex. This 
uncertainty is something that must be taken into account when trying to elucidate 
the actual acetylation targets of the ING4 complex. 
 
On an individual level HBO1 and ING4 have also been shown to interact 
physically and directly with p53, although the direct ING4-p53 interaction appears 
to be weak (Shiseki, et al., 2003; Zhang, et al., 2005; Palacios, et al., 2010). 
Thus far however, these interactions have only been studied in isolation, looking 
at each protein individually, rather than in the context of the ING4 complex. 
Similarly, the effects of p53 have only been examined on immunoprecipitated 
HBO1 HAT activity rather than in the context of a defined ING4 complex, and on 
free histones rather than on the more physiologically relevant chromatin 
substrate (Iizuka, et al., 2008).  
 
To better identify the direct histone modifying activities of the ING4 
complexes identified, we therefore aimed to set-up histone modifying assays in a 
biochemically defined system using the previously purified and reconstituted 
ING4 complexes. These assays would ultimately be performed on chromatin 
which would also allow a direct examination of ING4 complex histone modifying 
activity on a more physiological substrate. This would also allow any effects that 
the JADE and BRPF subunits might have on the activity of the ING4 complex to 
be elucidated. We also aimed to study ING4 complex activity in conjunction with 
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p53 and trimethylated H3K4 to directly determine if these conditions, as previous 
studies have suggested, would affect ING4 complex histone modifying activity. 
 
3.2 The central scaffold subunit confers H3 or H4 HAT preference to the 
ING4 complex HAT activity. 
 Using the purified endogenous ING4 ‘complex’ which contains both JADE 
as well as BRPF (designated ING4C) as well as the reconstituted JHIE and BHIE 
versions, we conducted HAT assays to analyze the catalytic capabilities. HAT 
assays utilizing ING4C on recombinant histones and purified HeLa nucleosomes 
show that ING4C acetylates free histones but that in the more restrictive and 
physiologically relevant context of a nucleosomal substrate, acetylation is 
restricted to histones H3 and H4, as has been previously reported (Doyon, et al., 
2006) (Fig 9A). 
 
Next we examined the acetylation by the ING4 complex in the context of 
chromatin. Chromatin was assembled using a p208ML p53 DNA template (Fig 
9B), recombinant histones and the ACF/NAP1 system (An & Roeder, 2004) (Fig 
9C). While ING4C was found to acetylate H3 and H4 equally well, the 
reconstituted BHIE and JHIE complexes demonstrated a strong preference for 
H3 and H4 acetylation respectively (Fig 9D). These observations further suggest 
that the purified ING4C is actually a combination of JADE-based and BRPF 
based-ING4-HBO1-hEAF6 complexes and that the net activity of ING4C is a  
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Fig 9. HAT activity of the ING4 complex. 
A) HAT activity of ING4C on 200ng of nucleosomes purified from HeLa cells or
200ng of individual recombinant histones using 3H radiolabeled acetyl-CoA. 
ING4C acetylates free histones, but is restricted to H3 and H4 in the context of 
nucleosomes. (Autoradiograph shows incorporation of 3H into 
nucleosomes/histones. Coomassie stain of the corresponding substrates used is 
included as a loading control). 
B) p208ML p53 DNA template containing five p53 response elements used to
assemble chromatin. 
C) Chromatin assembly and HAT assay outline. The DNA template, purified
chromatin assembly factors and recombinant histone octamers were incubated 
for 3 hours at 27’C to assemble the chromatin. p53 was added and incubated for 
a further 20 minutes at 27’C to allow binding to the p53 binding sites present on 
the DNA. Finally the HAT of interest and acetyl-CoA was added and incubated at 
30’C to allow the histone acetylation reaction to occur. 
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D) ING4 complex HAT assay on chromatin. ING4C acetylates H3 and H4 in the
context of chromatin, while JHIE preferentially acetylates H4 and BHIE 
preferentially acetylates H3. p53 has no detectable effect on HAT activity. 
(Autoradiograph) 
E) Time course of ING4C acetylation of chromatin using low levels of ING4C .
No detectable p53 effect on ING4C acetylation. (Autoradiograph) 
F) JHIE/BHIE HAT assay on chromatin. A very slight p53 dependent signal can
be observed with a long exposure. (Western blot with indicated antibody. The top 
row is a short exposure of the blot for two minutes while the bottom row is a 
longer exposure of the blot for thirty minutes) 
Fig 9. (continued)
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combination of JHIE (acetylating H4) and BHIE (acetylating H3) HAT activity. 
These observations also reveal a control over ING4 complex HAT specificity that 
is mediated by the central subunit (either JADE1L or BRD1) similar to what has 
been shown with the ING5 complex (Lalonde, et al., 2013). 
3.3 H3 acetylation by the ING4 complex is enhanced by trimethylated H3K4 
As a link between trimethylated H3K4 and ING4 mediated HAT activity 
has been observed, we next investigated the effect of H3K4me3 on the HAT 
activity of our ING4 complexes. In agreement with previously reported results, 
ING4C HAT activity on H3 peptides bearing the various K4 methylation states 
was increased when H3K4 was di- or trimethylated (Fig 10A) (Saksouk, et al., 
2009; Hung, et al., 2009). 
We further showed that this H3K4me3-dependent increase in H3 
acetylation also occurred in the context of chromatin via HAT assays on 
reconstituted chromatin. Chromatin was assembled with recombinant histones 
using either H3 that was unmodified at K4 or that bore the methyl-lysine 
analogue of trimethylated K4 (Lauberth, et al., 2013). Using equivalent amounts 
of chromatin (Fig 10B), some increase in H3 acetylation in the presence of 
trimethylated H3 could be detected with ING4C (Fig 10C). This increase can be 
seen more clearly in the case of Western blots done against individual acetyl-   
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Fig 10. H3K4me3-dependent ING4 complex HAT activity. 
A) 3H-labeled acetyl-CoA HAT assay on H3 peptides containing the N-terminal 1-
21 residues of H3 with different K4 methylation states provided by the 
Rockefeller University Proteomics Center. Counts per minute of each sample 
was assayed with scintillation. Results are from two independent experiments for 
me0 and me1 and three independent experiments for me2 and me3. Error bars 
indicate the standard deviation. 
B) H3K4me0 and H3K4me3 analog chromatin assemblies (chrom) used in
subsequent assays. (Coomassie stain) 
C) HAT assay on chromatin assembled with recombinant unmodified histones or
with histones with the H3K4me3 analog. A slight increase in activity is observed 
in the presence of H3K4me3. (Autoradiograph) 
D) Acetylation on H3K18 and H3K9 after chromatin acetylation by ING4C, JHIE
and BHIE. ING4C. ING4C acetylation of H3K9 and BHIE acetylation of H3K9 and 
H3K18 is enhanced by H3K4me3. (Western blot. The top four rows are short, two 
minute exposures of the blots while the bottom four rows are longer, thirty minute 
exposures of the same blots) 
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lysines. These blots revealed that acetylation of H3K9 by ING4C and H3K9 and 
H3K18 by BHIE, but not by JHIE, was increased in the presence of trimethylated 
H3K4 (Fig 10D). This is consistent with the observation that BRD1 mediates 
HBO1 H3 HAT specificity, while JADE1L mediates HBO1 H4 HAT specificity. 
Western blots were also conducted for H3K14 acetylation, but no signal was 
detected (data not shown). 
3.4 Interaction with p53 
3.4.1 ING4 and the ING4 complex are capable of direct physical 
interactions with p53 
ING4 has been shown to physically associate with p53 in the cell, 
although the assays in these cases have consistently used ectopically 
overexpressed ING4 (Shiseki, et al., 2003; Zhang, et al., 2005). To verify that the 
physical association is something that occurs normally with natural levels of 
ING4, endogenous ING4 was immunoprecipitated from doxorubicin treated 
HCT116 cells that contain functional p53. p53 was found to coIP with ING4 (Fig 
11A). These results are consistent with, but do not prove, a direct interaction 
since the contribution of other proteins to this association have not been ruled 
out. 
In vitro, a direct interaction has also been mapped out between purified 
p53 and ING4, although not in the context of the ING4 complex (Zhang, et al., 
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2005). To verify that this interaction can also take place in the context of the 
more physiologically relevant ING4 complex, binding assays were conducted 
with bacterially purified GST-p53 and the ING4 complex as well as with purified 
ING4 on its own (Fig 11B). These combined results showed that p53 can directly 
bind both to ING4 as isolated subunit and also to the ING4 complex as a whole. 
 
 Interactions between HBO1 and p53 have also been noted and were 
verified in vitro using purified components. In fact, every subunit of the ING4 
complex that was tested in an in vitro binding assay was observed to interact 
directly with p53 despite stringent wash conditions (Fig 11B). This begs the 
question of whether any of these p53 interactions are actually valid associations 
that occur in vivo, rather than non-specific interactions to some especially 
tractable region of p53. Regardless, these assays show that both ING4 as well 
as the ING4 complex is capable of binding directly to p53, at least under the 
conditions used in the in vitro assays both here and in the literature. 
 
 3.4.2 p53 does not directly affect ING4 complex HAT activity on 
chromatin 
 It has been shown that p300, another p53 cofactor that is a histone 
acetyltransferase and interacts with p53, is capable of increased acetylation of 
H3 and H4 in the context of chromatin in the presence of p53. In fact, while p300  
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Fig 11. ING4 complex interacts with p53. 
A) p53 coIPs with ING4. Endogeneous ING4 IP from HCT 116 cells treated with
doxorubicin. p53 association analyzed by Western blot. 
B) In vitro binding using purified ING4 complex subunits and GST-p53. Binding to
p53 was analyzed by Western blots against the FLAG-tagged subunit. 
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is able to acetylate free histones or nucleosomal substrates on its own, its ability 
to acetylate chromatin is almost completely dependent on the presence of an 
activator such as p53 (Espinosa & Emerson, 2001; An, et al., 2004). In light of 
this p53-dependent activity by a p53-associated histone acetyltransferase, it 
seemed possible that the ING4 complex, interacting with p53 and containing a 
histone acetyltransferase, might also have a p53 affected/dependent chromatin 
acetylation.  
 
To test this hypothesis, an ING4 complex HAT assay was carried out 
using chromatin assembled from recombinant histone octamers and purified 
factors. While, as previously observed in the literature, p300 acetylation of 
chromatin was strongly dependent on the presence of p53, histone acetylation by 
the ING4 complex seemed to be completely independent of p53, being equally 
strong in the presence of or absence of p53 (Fig 9D). Moreover, no p53 effect 
was observed even when lower amounts of the complex were used in a kinetic 
acetylation assay (Fig 9E compare lanes 9 with 10, and 11 with 12), which has 
been previously used to elucidate an activator-dependent histone acetylation on 
a similarly promiscuous HAT (Ikeda, et al., 1999). This p53 independence 
contrasts sharply with p300 mediated chromatin acetylation, which is strongly 
dependent on p53 (Fig 9E lanes 1 and 2). An extremely small effect can possibly 
be observed at H3K18 if the Western blot is exposed for an extended period of 
time, but this effect is so slight as to be negligible (Fig 9F compare lanes 4 with 5 
for JHIE and lanes 6 with 7 for BHIE). For comparison, the strong p53-dependent 
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p300 acetylation of these residues is also shown here (Fig 9F compare lanes 2 
and 3).  
 
Therefore, despite the potential direct physical interaction capable of 
forming between the ING4 complex and p53, the observed acetylation of 
chromatin by the ING4 complex under these assay conditions does not require 
and is not measurably influenced by the presence of p53. This is in contrast with 
a previous study that reported an inhibition of HBO1 HAT activity by p53 in vitro. 
However, as previously noted, that study used a crude HBO1 immunoprecipitate 
rather than purified ING4 complex and studied its effects on free histones rather 
than the more physiologically relevant chromatin substrate (Iizuka, et al., 2008). 
 
3.4.3 A synergistic p300-BHIE HAT activity that is dependent on p53 
 Cooperative effects have been observed between various p53 cofactors, 
such as p300 with PRMT1 and CARM1 (An, et al., 2004), MLL1 with MOF (Dou, 
et al., 2005), and p300 with SET1 (Tang, et al., 2013). Since both p300 
(Espinosa & Emerson, 2001; An, et al., 2004) and ING4 (Shiseki, et al., 2003; 
Zhang, et al., 2004; Doyon, et al., 2006) have been implicated in p53-dependent 
transcription from p21 or a p21 promoter it seemed possible that both proteins 
might work together. An attempt was thus made to see if there a cooperative 
HAT effect might be observed by combining the two activities together. 
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 To this end a HAT assay on chromatin was conducted using p300 and the 
JHIE and BHIE versions of the ING4 complex. Levels of p300 had to be 
substantially decreased from what is usually used in p300 HAT assays as the 
robust p300 acetylation of chromatin could be expected to mask any additional 
effect from the ING4 complexes that might be seen. Levels of JHIE and BHIE 
were also titrated to determine optimal conditions (data not shown). Under these 
conditions an increased histone acetylation was observed, with greater H3K9 
and H3K18 acetylation levels being observed when p300, JHIE and BHIE were 
used together (Fig 12A lane 15), compared to when either was used individually 
(Fig 12A lanes 3, 5 and 10). This effect is not simply a sum of the independent 
HAT activities since acetylation by JHIE and BHIE alone under these conditions 
is negligible, but rather a synergistic effect of their respective HAT activities. 
 
 To further investigate this synergistic effect, the assay was also done 
using JHIE or BHIE individually in combination with p300. The greatest HAT 
synergy was observed with when both p300 and BHIE were used together (Fig 
12A compare lane 14 with 13). This is consistent with earlier observations 
regarding the HAT specificity of BHIE and suggested that BHIE HAT activity 
might be enhanced by p300. Moreover, this HAT synergy by p300 and BHIE is 
strongly dependent on p53 (Fig 12A lanes 12 & 15), as is p300 HAT activity (Fig 
12A lanes 2 & 3), whereas, as shown earlier, BHIE HAT activity on its own is not   
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Fig 12. Cooperative p300 and ING4 complex HAT activity on chromatin. 
A) A p53-dependent p300-ING4 complex HAT synergy on both H3K4me0 and
H3K4me3 containing chromatin. (Western blot with the indicated antibodies) 
B) Scheme for ordering the p300 and BHIE acetylation on chromatin.
C) Ordered reactions of p300 and BHIE. p300 or BHIE or both were added to the
reaction as indicated to obtain sequential, simultaneous or individual acetylation 
by p300 and/or BHIE. Maximal synergy is obtained with p300 followed by BHIE 
acetylation. (Western blot with indicated antibodies) 
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p53-dependent (Fig 9D, compare lanes 17 & 18 with 19 & 20). A comparative 
analysis with templates assembled with H3K4me3 revealed no additional effect 
of trimethylated H3K4 (Fig 12A, compare H3K4me0 with H3K4me3 rows), 
suggesting that this synergy is not enhanced by the ING4 PHD finger-
trimethylated H3K4 interaction. 
 
One possible explanation for the p300-BHIE HAT synergy is that some 
level of histone acetylation by p300 might be a prerequisite for maximal BHIE 
HAT activity. If this were the case, the synergistic effect would be most 
noticeable if the HAT reaction were ordered, with p300 histone acetylation taking 
place first, followed by BHIE histone acetylation. To test this, the HAT reaction by 
p300 and BHIE was staggered, with one HAT added before the other (Fig 12B). 
As predicted, a p300 addition followed by BHIE addition showed the greatest 
synergy (Fig 12C lane 9), compared to BHIE followed by p300 (Fig 12B lane 11), 
BHIE and p300 added simultaneously (Fig 12C lane 13), or either p300 or BHIE 
added individually (Fig 12C lanes 3 & 7). As before, this activity was strongly 
dependent on p53 (Fig 12C lanes 8 & 9). Note that use of higher concentrations 
of p300 does mask this synergistic effect (Fig 12C compare lanes 4 & 5 with lane 
9), again emphasizing the need to avoid p300 saturation of the system. 
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3.5 Synergistic MLL1 complex-ING4 complex activity 
Having established that the core MLL1 complex was also present in the 
purified ING4 complex, the next question was if the MLL1 complex was 
catalytically active. A lysine methylation assay utilizing the ING4 complex-MLL1 
complex purified from HeLa cells were therefore conducted on chromatin 
assembled with recombinant histones. This assay determined that the MLL1 
complex was indeed catalytically active, being capable of monomethylating, but 
not trimethylating H3K4, as has been previously reported for this complex (Fig 
13B lane 6) (Tang, et al., 2013). 
Acetylation and methylation reactions require acetyl-CoA and SAM 
respectively as cofactors. By controlling when/if these cofactors are added to the 
reaction, the ability of the ING4 complex-MLL1 complex to acetylate or methylate 
histones can be ordered or restricted and the effects of the histone acetylation on 
H3K4 methylation and vice versa can be examined (Fig 13A). So, for example, 
incubating the complexes with SAM for a time period, and then adding acetyl-
CoA for a subsequent time period would result in methylation occuring first, 
followed by acetylation. From this assay, as would be expected, addition of 
acetyl-CoA resulted in H3 and H4 acetylation (Fig 13B lanes 2-5). However, 
addition of acetyl-CoA also led to an increase in monomethylation of H3K4 when 
added together with SAM, compared with SAM alone (Fig 13B compare lanes 2-
4 with 6). This increase was greatest when acetyl-CoA was added 
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Fig 13. H3K4 methylation of the MLL1 complex associated with ING4. 
A) Scheme for ordering the methyltransferase and acetyltransferase of the ING4
complex and associated MLL1 complex present in ING4C. The order of the 
methylation and acetylation is determined by controlling when the appropriate 
substrate is added in – 3H labelled acetyl-coA for acetylation and S-adenosyl 
methione (SAM) for methylation. 
B) ING4C-MLL1C HAT/KMT assay on chromatin. (Western blots with indicated
antibodies to determine methylation and autoradiography to determine 
acetylation) 
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simultaneously with SAM (Fig 13B lane 4). Conversely, addition of SAM had no 
significant effect on histone acetylation, regardless of the order of the reactions 
(Fig 13B compare lanes 2-4 with 5). To see if this enhancement could be 
enhanced by further histone acetylation, p300 and the p53 required for p300 
chromatin acetylation were added, but no further increase in K4 methylation was 
observed (Fig 13B lane 1). Therefore the ING4 complex HAT activity enhances 
MLL1 complex mediated H3K4 methylation, similar to what has been seen 
between p300 and SET1 complex H3K4 methylation (Tang, et al., 2013). 
 
3.6 Discussion 
From this study we can conclude that the primary determinant of histone 
acetylation specificity in the ING4 complex is the choice of the scaffold subunit 
that holds the complex together. A BRD1 complex preferentially acetylates H3 
while a JHIE complex preferentially acetylates H4, similar to what has been 
shown for the ING5 complex (Lalonde, et al., 2013). In contrast, purified ING4C, 
which contains both JADE and BRPF proteins, acetylates both H3 and H4 
equally. This is consistent with the hypothesis that the activity of the purified 
ING4C is in fact a combination of the activities of two distinct ING4 complexes. 
 
Using chromatin assembled with recombinant histones and purified 
factors, the HAT assays with both ING4C and the recombinant JHIE and BHIE 
have verified that H3 acetylation is increased by trimethylated H3K4. These 
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assays further identify H3K9 and H3K18 as two of the residues where this 
increase in acetylation takes place, and further establish H3K18 as an ING4C 
and BHIE acetylation target. More specifically, these assays show that this 
trimethylated H3K4-dependent activity occurs with BHIE and with ING4C (which 
we hypothesize contains the BRPF version as well as the JHIE version of the 
ING4 complex) but not with JHIE. 
While other groups have linked the JADE-containing ING4 complex to a 
trimethylated H3K4-dependent increase in H3 acetylation (Hung, et al., 2009; 
Saksouk, et al., 2009; Avvakumov, et al., 2012), those links were made based on 
ChIP assays or ING4 complexes whose precise composition remains unclear. In 
the former case, while ChIP assays can show an increase in a histone mark in 
response to an increase in JADE, the limitations of cell-based assays mean that 
there is no way to tell if the effect is a direct one. In the latter case, possible 
contamination with the BRPF-based ING4 complex means that the H3 
acetylation may not be due to the JADE-containing ING4 complex at all, but 
rather by a BRPF-containing ING4 complex. 
The acetylation of H3K14 has also been linked to the ING4 complex 
through overexpression, knockdowns and knockouts of various ING4 complex 
members (Saksouk, et al., 2009; Kueh, et al., 2011; Mishima, et al., 2011). 
However, in contrast to this in vivo correlation, our in vitro HAT assays using 
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purified ING4 complexes and chromatin assembled with recombinant naïve 
(unmodified) histones failed to show any H3K14 acetylation under any of the 
conditions examined (p53, p300, trimethylated H3K4). H3K14 acetylation may 
therefore not be a direct target of the ING4 complex, but could instead be a 
subsequent downstream effect of ING4 complex activity. For example, a 
subsequent recruitment of MOZ/MORF, which has been shown to acetylate 
H3K14 (Doyon, et al., 2006), could account for such a link between the ING4 
complex and H3K14 acetylation. Alternatively, given the number of chromatin 
recognizing domains present in the ING4 complex, it is possible that there is a 
histone mark missing from the naïve chromatin used here that is a prerequisite 
for H3K14 acetylation by the ING4 complex. 
 
ING4 effects on cell growth and activation of p53 target genes is 
dependent on p53 (Shiseki, et al., 2003; Zhang, et al., 2004) and a direct 
physical interaction between p53 and components of the ING4 complex has been 
shown in this study and elsewhere (Zhang, et al., 2005, Iizuka, et al., 2008). 
However no direct p53-dependent effect on ING4 complex histone acetylation of 
any significance was observed in any of the in vitro HAT assays. What then 
accounts for the ING4 dependency on p53 that is observed in cells? One 
pathway by which this might be accomplished is through the establishment of 
trimethylated H3K4 via the SET1 complex, a pathway that has been shown 
elsewhere to be p53-dependent (Tang, et al., 2013). Another pathway is the one 
that has been established here, through ING4 complex synergy with p300 (Fig 
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14). So while there is no direct effect of p53 on ING4 complex HAT activity, there 
are at least two indirect pathways by which a p53 effect on ING4 complex activity 
is apparent. Future studies involving the integration of all of these pathways 
might further uncover additional mechanisms by which p53 affects ING4 complex 
activity. 
 
Lastly we have described here a novel interaction between the ING4 
complex and the MLL1 complex and shown that ING4 complex activity is capable 
of enhancing H3K4 monomethylation by the MLL1 complex. However the 
functional role of this H3K4 monomethylation in the context of ING4 complex 
activity is unclear. It could be a precursor to H3K4 di- or trimethylation, leading in 
turn to additional ING4 complex H3 acetylation in a feed-forward loop, or it could 
act as a mark that serves to recruit some other protein or protein complex. These 
are two possible avenues of further investigation, although both would require the 
identification and incorporation of additional interacting factors. 
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Chapter 4 
Mediation of transcription by the 
ING4 complex
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4.1 Preface 
 Members of the ING4 complex have been linked to transcriptional activity 
in various ways. As mentioned previously, overexpression of ING4 leads to 
activation of p21 and BAX genes in a p53-dependent manner (Shiseki, et al., 
2003; Zhang, et al., 2004) and overexpression of HBO1 was found to have a 
similar effect (Avvakumov, et al., 2012). Knockdowns of HBO1 in 293T cells 
decrease overall levels of H4K5, K8 and K12 acetylation (Doyon, et al., 2006) 
while knockouts of HBO1 and BRD1 in mice lead to a depression of 
transcriptional activity of various genes and an overall decrease in H3K14 
acetylation (Kueh, et al., 2011; Mishima, et al., 2011).  
 
ING4 and its complex members have been further linked to transcription 
activity by establishing their presence on genes via ChIP assays. Ectopically 
expressed ING4, JADE1L, BRD1 and HBO1 have been shown to localize around 
the TSS of genes, to colocalize with various histone modifications, and to 
correlate with actively transcribed genes. ING4 colocalizes with acetylated H3K9 
and trimethylated H3K4 on SMC4 (Hung, et al., 2009) while JADE1L was shown 
to colocalize with trimethylated H3K4 and acetylated H3K14 and H4K8 at the 
TSS of EXT1 and FOXP4 as well as further down the body of the genes where it 
colocalized instead with trimethylated H3K36 (Saksouk, et al., 2009). The 
catalytic subunit HBO1 tends to colocalize with BRD1 on genes that are 
transcriptionally active (Mishima, et al., 2011) and correlates with acetylated 
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H3K14 on the coding region of genes (Kueh, et al., 2011). Altogether these 
results suggest that ING4 and its complex members correlate with transcription 
and transcriptionally associated histone acetylation. 
 
  With regard to p53-associated transcription, endogenous HBO1, BRD1 
and its BRPF1 paralog, as well as the ING5 protein, have been shown to bind to 
the region around the TSS of the p53 target p21 gene (Avvakumov, et al., 2012; 
Lalonde, et al., 2013). Taken together with the more general links made between 
ING4 complex subunits and transcriptional activation as well as the observed link 
between ING4 and p21 expression, these results suggest that ING4 and ING4 
complex subunits could potentially act in conjunction with p53 to activate a p53 
target gene. 
 
 Caution, however, must be taken in the extrapolation of these results to 
the ING4 complex. While JADE1L, HBO1 and BRD1 are members of the ING4 
complex, they are not found exclusively in the ING4 complex. So while results 
involving these proteins can tentatively suggest ING4 complex enrichment and 
activity, the only protein that can be used to conclusively extrapolate ING4 
complex enrichment and activity is ING4 itself. Additionally, the use of ectopically 
overexpressed proteins in the ChIP assays may not reflect the enrichment that 
occurs normally with the endogenous protein. Finally, previous ING4 and ING4 
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complex subunit ChIPs that have looked at p21 occupancy have only looked at 
occupancy on p21 in the absence of p53 activation. 
 
 Therefore the first thing we aimed to do was to study the enrichment of 
endogenous ING4 (and thus the ING4 complex) on a p53 target gene and to 
correlate this with p53-dependent gene activation. We then planned to 
complement these cell-based correlations by directly investigating the 
contribution of the ING4 complex to transcription in the context of a p53-
dependent in vitro transcription system from chromatin templates. Guided by our 
histone modification studies, we would then use this system to look at conditions 
that affect the ING4 complex histone modifying activity to see if these might be 
translated into an effect on transcription. 
 
4.2 ING4 enrichment on p21 
 4.2.1 ING4 recruitment to p21 correlates with gene activation 
 To better determine the activity of the ING4 complex in association with 
transcription under endogenous protein conditions, ING4 ChIP assays were 
conducted against endogenous ING4 in HCT116 cells (which contain wild type 
p53) that had been with treated with the DNA damaging reagent doxorubicin in 
order to activate transcription of p53 target genes. The enrichment of ING4 
around the TSS of p21 (where HBO1, BRPF1/2 and ING5 have previously been 
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shown to localize (Avvakumov, et al., 2012; Lalonde, et al., 2013) was 
subsequently examined by quantitative PCR.  
 
Under conditions of doxorubicin treatment, ING4 was enriched at the p21 
TSS and the region immediately downstream compared with untreated cells (Fig 
14B). This enrichment was further accompanied by an increase in acetylated 
H3K9 (Fig 14C). As this region is also enriched with trimethylated H3K4 (Tang, et 
al., 2013), ING4 occupancy on p21 correlates with trimethylated H3K4 (which is 
recognized by the ING4 PHD finger), acetylated H3K9 (which is acetylated by 
HBO1 in the ING4 complex), and p53 gene activation. This is consistent with the 
results of the in vitro HAT assays, which show that the ING4 complex binds to 
trimethylated H3K4 and acetylates H3K9.  
 
4.2.2 ING4 recruitment to p21 is dependent on p53 
 While p53 has no direct effect on ING4 complex chromatin acetylation in 
vitro, this study has shown than an indirect p53-dependent effect does exist. It is 
thus possible that p53 would also have an indirect effect on recruitment and 
histone acetylation of ING4 on p21 in the cell. To investigate this possibility, an 
ING4 ChIP was conducted on HCT116 p53 knockout (p53 -/-) cells. As can be 
seen, the absence of p53 caused a substantial reduction in occupancy of ING4 
on p21 compared to the p53-containing HCT116 cells (Fig 14D). The increase in 
levels of acetylated H3K9 from the untreated to the treated cells were also   
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Fig 14. ING4 enrichment around the p21 transcription start site (TSS) 
correlates with gene activation by p53 and correlates with increased 
H3K9ac enrichment. 
A) Diagram of p21 gene with location of sites targeted by ChIP primers indicated
by arrows. Sites were selected based on observations that members of the ING4 
complex tend to localize to the area immediately around the TSS. (Red line: TSS. 
p53 RE: p53 response element. The ladder shows the distance in Kb from the 
TSS) 
B-E) ChIP assays on HCT 116 cells treated and untreated with doxorubicin. 
Results are from two independent assays. Error bars show the standard error. 
(con: control (untreated) cells. dox: cells treated with 0.5mM doxorubicin for 4 
hours. p53 -/-: p53 knockout cell line.) 
B) Doxorubicin treatment causes an increase in ING4 enrichment at the TSS and
immediately downstream of the TSS of p21 compared to control cells. 
C) Doxorubicin treatment causes an increase in H3K9ac enrichment that
correlates with ING4 enrichment compared to control cells. 
D) In the absence of p53, ING4 enrichment upon doxorubicin treatment is
decreased compared to control cells. 
E) In the absence of p53, H3K9ac enrichment upon doxorubicin treatment is
decreased compared to control cells. 
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reduced (Fig 14E), which is what would be predicted if such acetylation were due 
to the ING4 complex. Thus, in the cell the recruitment of ING4 to p21 is 
dependent on p53, as is the enrichment of H3K9 acetylation upon doxorubicin 
treatment. 
 
4.3 p53-dependent, ING4 complex-mediated in vitro transcription 
 The described cell-based assays have provided clues as to the activity of 
the ING4 complex with respect to transcription in general and p53-mediated 
transcription in particular. However, the recurring limitation with such cell-based 
assays is that they are unable to show a direct causative effect of the ING4 
complex on the transcriptional activation of target genes (p53 or otherwise). This 
difficulty is compounded by the multiple roles that ING4 and its complex are 
suspected to play in the cell. In addition to its role in p53-dependent gene 
activation, ING4 has also been implicated in the repression of NF-κB and HIF-1α 
pathways (Coles & Jones, 2009), while HBO1 plays a vital role in DNA replication 
(Burke, et al., 2001) and regulation of genes involved in erythropoiesis and 
embryonic patterning (Mishima, et al., 2011; Kueh, et al., 2011). The multiplicity 
of possible ING4 complex effects in the cell thus makes it difficult to elucidate 
ING4’s precise role in p53 mediated transcription in such as system. 
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 The strategy used here to resolve this dilemma is to study the effects of 
the ING4 complex in conjunction with p53 via an in vitro chromatin transcription 
system (Fig 15A). The use of such an in vitro system allows for the elimination of 
extraneous variables and indirect effects of the ING4 complex on p53-mediated 
transcription by changes in the expression of other genes or effects on DNA 
replication and the cell cycle. This allows for more focused conclusions on the 
ING4 complex’ direct effects on p53-mediated transcription to be drawn. 
 
 4.3.1 The ING4 complex has a direct effect on p53-mediated 
transcription from chromatin templates 
 In vitro transcription assays on chromatin showed that while p53 alone 
had a minimal effect (Fig 15B lane 2), addition of the ING4C with p53 
substantially enhanced transcription to a level comparable to what is seen with 
p300 (Fig 15B lanes 3 & 4). This demonstrates that ING4C does indeed function 
directly to enhance p53-mediated transcription and that ING4, in the context of its 
complex, does function as a transcriptional coactivator for p53. This effect was 
also observed using both of the reconstituted JHIE and BHIE. While JHIE or 
BHIE alone resulted in some p53-dependent transcription, transcription levels 
increased when both were used together (Fig 15C). Note, however, that this 
required titration of proteins since higher concentrations of JHIE and BHIE inhibit 
transcriptional activity (Fig 15D). This suggests that both the JADE and BRD  
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Fig 15. ING4 complex effects on p53-mediated transcription from chromatin 
templates. 
A) Outline of in vitro transcription assay from chromatin templates.
B) ING4C enhances p53-dependent transcription on chromatin templates. 30ng
of p300 and 20ng of ING4C were used. 
C) JHIE and BHIE cooperate to enhance p53-dependent transcription. 7.5 ng of
JHIE and 6ng of BHIE were used. 
D) Excess JHIE and BHIE inhibit transcription. JHIE titration is from 15-60ng.
BHIE titration is from 15-120ng. 
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versions of the ING4 complex are required for optimal HBO1/ING4-based p53 
coactivator functions, and that JHIE and BHIE are both required to properly 
reconstitute purified ING4C activity. 
 
Previous work has established the importance of joint H3 and H4 
acetylation by p300 for p53-dependent transcription from chromatin (An, et al., 
2004). In the in vitro transcription assays done here however, the addition of 
ING4C or JHIE and BHIE in the absence of p300 is sufficient to allow p53-
dependent transcription. This suggests that it is the HAT activity of the ING4 
complex that is important for its effect on chromatin transcription, and that the H3 
and H4 acetylation supplied by ING4C or jointly by JHIE and BHIE is sufficient to 
allow this transcription. The fact that JHIE, which gives predominantly H4 
acetylation, and BHIE, which gives mostly H3 acetylation, resulted in less 
transcription on their own than together supports the importance of both H3 and 
H4 acetylation for transcription from chromatin (Fig 15C). 
 
4.3.2 ING4 complex-mediated transcription activity is enhanced by 
trimethylated H3K4 
 Having established that trimethylated H3K4 has a positive effect on 
ING4C and BHIE HAT activity, it seemed possible that this could also translate to 
a trimethylated H3K4-dependent effect on ING4C transcriptional activity. To 
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investigate this possibility, in vitro transcription assays were conducted with 
chromatin templates assembled with the trimethylated H3K4 analogue (Simon, et 
al., 2007) and carried out in conjunction with p300. As before, levels of p300 had 
to be titrated down to prevent masking of any ING4 complex contributions. 
ING4C used was similarly titrated to determine optimal concentrations (data not 
shown).  
 
 Under these conditions with reduced levels of p300, the presence of 
trimethylated H3K4 was crucial to ING4C-dependent as well as p300-dependent 
p53-mediated transcription (Fig 16A lane 4). This activity was dependent on p53 
and acetyl-CoA, with no significant transcriptional activity observed in the 
absence of p53 or acetyl-CoA (Fig 16A compare lanes 4 with 7 & 9). The p53-
dependency is consistent with ING4’s role as a p53 coactivator rather than as an 
independent transcription activator of its own. The acetyl-CoA dependency 
further suggests that it is the ING4C HAT activity that is responsible for its 
contribution to transcription. As with the reconstituted JHIE and BHIE, the 
amount of ING4C used here is critical, as too much of it seems to inhibit 
transcriptional activity (Fig 16A compare lanes 4 & 5). 
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4.3.3 ING4 complex-mediated transcription activity is enhanced by 
p300 
 The synergy previously noted between p300 and the ING4 complex HAT 
activity, and the established link between histone acetylation and transcription, 
suggested the possibility of transcriptional synergy between p300 and the ING4 
complexes. In fact addition of both p300 and ING4C resulted in a slight increase 
in transcriptional activity (Fig 16A compare lanes 3 & 4 with 6). As the HAT 
synergy between p300 and the ING4 complex was most apparent when they 
were added sequentially to the reaction, the in vitro transcription assay was 
similarly modified so that p300 was allowed to acetylate chromatin prior to the 
addition of JHIE and BHIE (Fig 16B). This ordered reaction, as with the HAT 
activity, gave greater levels of transcription than either p300 or JHIE and BHIE 
alone (Fig 16C lanes 4, 5, 7 & 8) and is dependent on p53 (Fig 16C lanes 8 & 9). 
This correlation between HAT synergy and transcription synergy further supports 
the link between histone acetylation and transcription. 
 
 This cooperative effect between p300 and the ING4 complex also allows 
lower levels of p300 to be used than is normally required to see the p53-
dependent transcription in the p300 only system. So while it is possible to 
overcome the lack of other HATs by using an excess of p300, the inclusion of the 
JHIE and BHIE, which reflects the more physiological condition found in the cell  
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Fig 16. Factors that enhance ING4 complex histone acetylation enhance 
ING4 complex-mediated p53-dependent transcription. 
A) In vitro transcription assay on chromatin comparing chromatin incorporating
naïve (unmodified) histone octamers and chromatin incorporating the H3K4me3 
analogue, with reduced levels of p300 (12.5ng) and ING4C (6 or 12ng). 
B) Outline for of in vitro transcription assay with sequential p300 and JHIE/BHIE
histone modification. 
C) In vitro transcription assay on chromatin modified by p300 or JHIE/BHIE
individually, or sequentially by p300 then by JHIE/BHIE. 12.5ng of p300 was 
used with 7.5 or 15ng of JHIE and 6 or 12ng of BHIE. 
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where all these HATs are present, allows transcriptional activity to be obtained 
with ~3 fold lower concentration of p300. 
 
4.4 Discussion 
 The ChIP assays conducted here show that endogenous ING4 enrichment 
on the p21 promoter is enhanced upon activation of the p21 gene. This is 
consistent with the hypothesized role of ING4 and ING4C in the activation of 
genes. In keeping with what is known about ING4C histone acetylation activity, 
this enrichment is correlated with trimethylated H3K4 and H3K9 acetylation. This 
is what would be expected if ING4C were mediating transcription by recognizing 
trimethylated H3K4 and acetylating histones. Furthermore, by using a p53 
knockout cell line, this study establishes that the association of ING4 and 
acetylated H3K9 on the p21 TSS in response to doxorubicin treatment is 
dependent on p53. 
 
 Note that while these assays show the p53 dependency of ING4 
recruitment to p21, it does not mean that this dependency is direct. In fact the 
data available suggest that ING4 is recruited primarily to the TSS of p21 rather 
than the p53 response elements (Avvakumov, et al., 2012; Lalonde, et al., 2013). 
This is a different enrichment pattern from p300, which is recruited to the p53 
response elements (Dr Wei Yi Chen, Rockefeller University, unpublished data). 
The recruitment of p300 and the ING4 complex to different regions of p21 may 
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be indicative of the different pathways by which they are recruited by p53. p300 
is directly recruited by p53 and colocalizes with p53 at the p53 response 
elements upon gene activation. In contrast, the HAT activity of the ING4 
complexes is not directly dependent on p53, and ING4 is not recruited to the p53 
response elements. Rather, it is recruited to the TSS where it colocalizes instead 
with trimethylated H3K4.  
 
 Having established that ING4 is indeed associated with a p53 target gene 
under conditions of gene activation and that this association is dependent on 
p53, we then turned to an in vitro approach in order to overcome the limitations of 
cell-based assays. In contrast to all previously conducted assays associating the 
ING4 complexes with transcription, the in vitro transcription system established 
here demonstrates conclusively the direct effect of the ING4 complexes on p53-
mediated transcription. This directly demonstrates its role as a transcriptional 
coactivator of p53. Furthermore it shows that in the context of this transcription 
system, in the absence of p300, ING4 complex activity is necessary for p53-
mediated transcription and that this activity only occurs when acetyl-CoA, a 
necessary cofactor for acetylation is present. Lastly it shows that ING4 complex 
activity is capable of supporting p53-mediated transcription without any other 
ectopically added HATs, with the caveat that contributions from endogenous 
proteins in the nuclear extract used for the transcription cannot be ruled out. 
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In conjunction with what is known about the requirements for p300 H3 and 
H4 acetylation from the transcription assays done elsewhere using p300 and p53 
(An, et al., 2004), and the known H3 and H4 acetylation specificity of the ING4 
complexes, the logical conclusion would be that in this ING4 complex-dependent 
p300 independent system, the necessary H3 and H4 acetylation is being 
supplied by the ING4 complex. This is further corroborated by the fact that 
transcription attempted with the reconstituted JHIE or BHIE alone, which give 
predominantly H4 alone or H3 acetylation alone respectively, is substantially 
reduced, while using both JHIE and BHIE to supply the both H3 and H4 
acetylation maximizes the transcription. 
 
 In contrast to the basal ING4 complex HAT activity on chromatin, which is 
p53 independent, the ING4 complex-mediated transcription of chromatin is highly 
dependent on p53. Histone acetylation by the ING4 complex is therefore 
insufficient to potentiate transcription on its own, but in conjunction with p53 
allows transcription from chromatin, potentially as a function of ING4 complex 
histone acetylation. In fact, the ING4 complex-mediated effect on transcription 
correlates exactly with the HAT activity of the ING4 complex. Where greater 
histone acetylation is obtained by using both JHIE and BHIE complexes together, 
greater transcription is also observed. Where trimethylated H3K4 enhances the 
HAT activity of the ING4 complex, ING4 complex-mediated transcription in the 
presence of trimethylated H3K4 is also enhanced. Finally when HAT synergy is 
obtained by allowing sequential acetylation by p300 followed by the ING4 
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complex, transcriptional synergy is also obtained. Altogether, these observations 
provide strong, if circumstantial, evidence that the ING4 complex HAT activity, 
which is enhanced by p53-dependent p300 histone acetylation and p53-
dependent trimethylated H3K4, is what is responsible for its effect on p53-
mediated transcription. 
 
 However, this does not rule out other mechanisms by which the ING4 
complex might also affect p53-dependent transcription. Acetylation of non-
histone proteins could also play a role, or the ING4 complex might recruit other 
proteins/protein complexes and activities, such as the MLL1 complex and its 
H3K4 methylation activity. In fact, given the complexity of the transcriptional 
processes and the wide array of interactions that the ING4 complex is 
responsible for, it is very likely that there are other mechanisms yet to be 
discovered by which the ING4 complex affects transcription. 
 
 The establishment of an in vitro transcription system from chromatin that is 
dependent on both p53 and the ING4 complex is one that will be of great use in 
the further study of the ING4 complex and its contributions to p53-mediated 
transcription, allowing for biochemical in addition to cell based analyses of ING4 
complex activity. The use of naïve (unmodified) chromatin templates in 
conjunction with other histone modifiers such as p300, as analyzed here, or other 
cofactors (such as SET1) known to function with p53 would allow a more 
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comprehensive approach to studying p53-mediated transcription. This, in turn 
would more accurately reconstitute and reflect the in vivo activities of p53 gene 
activation. 
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Chapter 5 
Models and perspectives 
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5.1 Mechanism of ING4 complex p53-dependency 
 The premise behind the hypothesis that ING4 acts as a p53 cofactor was 
that its inhibitory effects on cell growth through cell cycle arrest and apoptosis 
were dependent on p53. This premise was further supported by current studies 
showing p53-dependent enrichment of ING4 and ING4 associated H3K9 
acetylation at the TSS of p21 upon conditions that activate p21. However, 
biochemical dissection of ING4 complex activity on chromatin revealed no 
significant direct effect of p53 on the HAT activity of the ING4 complex. So while 
ING4 is functionally dependent on p53 in terms of its effects in the cell, its ability 
to acetylate histones in the context of chromatin is not directly dependent on p53. 
How then does this functional p53 dependency come about? We propose here 
two non-mutually exclusive pathways by which p53 can indirectly effect ING4 
complex HAT activity and thereby, to ING4 complex-mediated activation of p53 
target genes. 
 
5.1.1 Synergy of the ING4 complex with p53-dependent p300 activity 
 While p53, on its own, does not affect ING4 complex HAT activity on 
chromatin in any observable way, the ING4 complex and p300 together exhibit 
synergistic HAT activity that is dependent on p53. The fact that optimal HAT 
activity was achieved when the HATs were added sequentially, with p300 first 
and BHIE second, suggests that the p53-dependent p300 HAT activity primes 
the chromatin for subsequent ING4 complex-mediated histone acetylation (Fig 
102 
 
17), which affects subsequent transcription. One possible explanation for this 
priming can be drawn from the observation that this synergistic effect is seen 
primarily with the bromodomain containing BHIE version of the ING4 complex 
rather than the JHIE version of the ING4 complex which does not contain a 
bromodomain. This suggests that the bromodomain recognition of a p300 
acetylated lysine residue on a histone tail may be responsible for the enhanced 
BHIE HAT activity observed. This might function to stabilize the protein complex 
on chromatin in the same way that bromodomain recognition of acetyl-lysines 
stabilizes p300 on chromatin (Tang, et al., 2013). 
 
 Another possibility for this synergistic HAT activity is based on the ING4 
association with p300 (Shiseki, et al., 2003). A physical interaction between the 
ING4 complex and p300 might allow an alternative pathway by which p53 could 
indirectly affect ING4 complex activity. In this case, the p53 would recruit p300 
which would in turn interact with the ING4 complex and enhance its activity on 
chromatin. 
 
 Further investigation will be required to determine if either or both of these 
possibilities are indeed responsible for the p53-dependent p300-ING4 complex 
effects on histone acetylation and transcription. A bromodomain mutation would 
allow analysis of its contribution to the p300-ING4 complex synergy while an 
HBO1 mutation that results in inactivation of the catalytic MYST domain would  
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Fig 17. p53-dependent ING4 complex HAT activity through p300. 
i) p53 binds to p53 response elements (p53 RE) and recruits p300. p300
acetylates histones and is stabilized on chromatin by p300 bromodomain-acetyl 
lysine interactions. 
ii) The BRPF bromodomain of the ING4 complex interacts with the acetyl-lysines
and allows additional histone acetylation by the ING4 complex. The ING4 
complex may be further stabilized on chromatin by possible interactions with 
p300. 
Blue arrows represent histone acetylation activity. Black arrows represent 
physical interactions. Dashed black arrow represents a possible (but 
unconfirmed) physical interaction. ac: Histone acetylation. 
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allow a more conclusive link to be made between the ING4 complex HAT activity 
and its effects on both the observed HAT synergy as well its contributions to 
transcription. The determination of the acetyl-lysines that are bound by the BRPF 
bromodomain and whether it binds acetylated lysines in general or is restricted to 
specific acetylated lysines on H3 and H4 would also be interesting. 
 
5.1.2 Cooperativity with p53-dependent H3K4 trimethylation 
 While not shown here, the link between p53 and H3K4 trimethylation on 
p53 target genes have been made elsewhere. What has been shown here is that 
H3K4 trimethylation does positively affect ING4 complex HAT activity. This 
allows for another pathway by which p53 could indirectly affect ING4 complex 
HAT activity on chromatin. It has been shown that p53 recruits p300, which in 
turn stabilizes the SET1 complex on chromatin and leads to trimethylation of 
H3K4 (Tang, et al., 2013). As an extension to that model, the ING4 complex 
could then be recruited to the chromatin through ING4 PHD finger recognition of 
the trimethylated H3K4, which allows subsequent histone H3 acetylation and 
transcription activation by the ING4 complex in conjunction with p53 and p300 
(Fig 18). 
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Fig 18. p53-dependent ING4 complex HAT activity through H3K4me3. 
i) p300 is recruited to chromatin by p53 and is stabilized on the chromatin via
bromodomain-acetyl lysine interactions. The SET1 complex (SET1C) is recruited 
by p53 and p300 and trimethylates H3K4. 
ii) The ING4 complex binds to trimethylated H3K4 via its ING4 PHD finger,
allowing additional histone acetylation by the ING4 complex. 
Blue arrow represents histone acetylation activity. Black arrows represent 
physical interactions. Red arrow represents H3K4 trimethylation activity. ac: 
Histone acetylation. K4me3: Trimethylated H3K4 
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An interesting future experiment to consider would be to employ SET1 
complex-mediated H3K4 trimethylation in conjunction with the p53-dependent, 
p300-ING4 complex dependent chromatin acetylation and transcription system 
used here. Such an experiment would integrate all histone modifications into one 
contiguous set of reactions and allow a more cohesive conclusion to be drawn 
rather than via extrapolating from individual experiments. 
 
5.2 Expanding the ING4 complex epigenetic vocabulary 
5.2.1 Simultaneous reading from differently marked histones 
 The multiplicity of histone readers present in the ING4 complex, some of 
which read mutually exclusive histone marks (ING4 PHD recognizing 
trimethylated H3K4 and the JADE and BRPF PHD1 recognizing unmethylated 
H3K4) begs the question of how these multiple readers integrate their input on 
chromatin. The size of the histone reading modules and the crystal structures 
available for modules binding to histone tails preclude the possibility of multiple 
modules reading the same histone tail at the same time due to steric hindrance. 
The possibility exists, however, of simultaneous binding of multiple histone 
reading modules to different histone tails, either within the same nucleosomes, or 
on multiple nucleosomes. 
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One intriguing possibility that this suggests is this use of the JADE/BRPF 
PHD1 and the ING4 PHD fingers to simultaneously bind to nucleosomes at a 
trimethylated H3K4-unmethylated H3K4 boundary. In conjunction with HBO1 
HAT activity, this could be one possible mechanism by which acetylation of 
histones on unmethylated H3K4 could be influenced by the trimethylation of 
H3K4 on an adjacent nucleosome. This acetylation could in turn stimulate 
methylation of the unmethylated H3K4 by the MLL1 or SET1 complex, providing 
a pathway by which H3K4 methylation could be spread outwards from an existing 
trimethylated H3K4 bearing nucleosome (Fig 19). 
5.2.2 ING4-ING4/ING4-ING5 complex dimerization 
The ability of the ING4 LZL region to form homodimers with the LZL 
regions of other ING4 molecules and the predicted ability to form heterodimers 
with the LZL regions of ING5 molecules raises the possibility of ING4-ING4 and 
ING4-ING5 (as well as ING5-ING5) complex dimmers. This would dramatically 
expand the number of histone binding domains and catalytic histone modifying 
domains that could be assembled into a single entity. For example, a dimer that 
contains both JADE as well as BRPF versions of the ING4 complex would be 
possible, combining the H3 acetylation preference of BRPF complex with the H4 
aceylation preference of JADE complex. A dimer that contains both HBO1 and 
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Fig 19. Exploiting the H3K4me3-H3K4me0 nucleosomal boundary through 
binding of the ING4 complex to adjacent H3K4me3 and H3K4me0 
containing nucleosomes. 
i) The ING4 complex binds to adjacent nucleosomes via ING4 PHD interactions
with H3K4me3 and JADE/BRPF PHD interactions with H3K4me0 at the 
H3K4me3-H3K4me0 nucleosome boundary. The ING4 complex acetylates H3 & 
H4 on the H3K4me3 nucleosome but only H4 on the H3K4me0 nucleosome. 
ii) Acetylation on the H3K4me0 nucleosome allows a p300 stabilized SET1
complex to trimethylated H3K4, creating a new H3K4me3-H3K4me0 boundary. 
iii) The ING4 complex binds to the newly trimethylated H3K4 nucleosome and
adjacent H3K4me0 nucleosome. 
Blue arrows represents histone acetylation activity. Black arrows represent 
physical interactions. Red arrow represents H3K4 trimethylation activity. ac: 
Histone acetylation. K4me3: Trimethylated H3K4. K4me0: Umethylated H3K4 
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MOZ/MORF would also be possible, leading to coordination between the H3 and 
H4 acetylation by HBO1, and MOZ/MORF-mediated H3K14 acetylation (Ullah, et 
al., 2008).  
 
The increased availability of multiple histone binding domains would also 
increase the affinity of the overall dimer for chromatin (Ruthenburg, et al., 
2007b), as well as allowing the specific recognition of a more extensive 
combination of histone marks. Dimerization would likewise increase the physical 
distance over which nucleosomes could be bound and modified by the dimerized 
complex, compared to a single undimerized complex. Further studies looking 
beyond the dimerization of ING4 to dimerization of the ING4 complex would 
therefore be useful in studying the full scope of what the ING4 complex can do in 
terms of coordinated recognition and modification of histones. 
 
5.2.3 Effects of recognition of other histone marks 
 While this study has focused primarily on the recognition of trimethylated 
H3K4 and its effects on the HAT activity of the ING4 complex, the effects of 
many other histone marks that are recognized by the ING4 complex on ING4 
complex activity have yet to be fully elucidated. The BRD1 bromodomain 
recognition of acetylated lysines has been proposed as a possible mechanism for 
the p300-ING4 complex HAT synergy, but has yet to be investigated. The 
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specificity of such recognition to a particular lysine or lysines on histones has 
also yet to be discovered.  
 
Similarly, while the effect of trimethylated H3K4 recognition compared to 
unmethylated recognition of H3K4 by the ING4 complex on H3 acetylation has 
been examined on several specific H3 residues, the same has yet to be done for 
H4, with studies to date looking at overall H4 acetylation via radiography rather 
than at specific residues. An ING4 complex modulated H4 acetylation specificity 
in response to unmethylated vs trimethylated recognition of H3K4 remains a 
possibility to be elucidated. 
 
 Lastly, while the recognition of the JADE PHD1 and BRPF PWWP domain 
to trimethylated H3K36 has been noted, no further study of the effects of such 
recognition on the HAT activity of the ING4 complex has yet been conducted. 
Investigating the effects of this mark on ING4 complex activity would be useful to 
better understand the mechanism by which the ING4 complex mediates 
transcription. 
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Chapter 6 
Methods and Materials 
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6.1 cDNAs 
 ING4 and JADE1L cDNAs were amplified from HeLa cell RNA by RT-
PCR. HBO1 (Gene accession number: BC032640) and hEAF6 (BG702589) 
cDNAs were purchased from Open Biosystems, while BRD1 (BC030007) cDNA 
was purchased from ATCC. 
 
6.2 Antibodies 
 The following antibodies were used for ChIP, co-IP and immunoblots: 
ING4 (Dr Zhanyun Tang, Rockefeller Univeristy), JADE1L/PHF17 (Abcam), 
BRD1/BRPF2 (Abcam), HBO1 (Santa Cruz Biotechnology), hEAF6/C1orf149 
(Santa Cruz Biotechnology), H3K4me3 (Abcam), H3K4me1 (Abcam), H4K8ac 
(Abcam), H3K9ac (Abcam), H3K14ac (Millipore), H3K18ac (Abcam), MLL1C 
(Dou, et al., 2005), RBBP5 (Bethyl Laboratories), WDR5 (Bethyl Laboratories), 
ASH2L (Bethyl Laboratories) and p53 (Santa Cruz Biotechnology). 
 
6.3 Purification and reconstitution 
A stable HeLa/Tet-on cell line (Tang, et al., 2013) expressing FLAG-ING4 
was obtained from Dr Zhanyun Tang. Doxoycline (Sigma) was used to induce 
expressing of FLAG-ING4 for 36 hours and the treated cells lysed in SDS sample 
buffer and blotted for ING4 to determine conditions where ectopic ING4 
expression was approximately equal to endogenous ING4 expression. Under 
117 
 
these conditions nuclear extracts were prepared from the cells as previously 
described (Dignam, et al., 1983) except that extract was dialyzed to 300mM 
rather than 100mM KCl. The extract was fractionated through a phosphocellulose 
(Whatman P11) column equilibrated with BC300 (BC0 (20mM Tris-HCl (ph 7.9), 
0.2mM EDTA, 20% glycerol, 0.2mM phenylmethylsulfonyl fluoride (PMSF) and 
10mM β-mercaptoethanol) with 300mM KCl) with 0.1% NP-40, and the BC500 
fraction (BC0 with 500mM KCl) containing ING4 and HBO1 was dialyzed in BC0 
to a final salt concentration of 0.3M KCl. This fraction was cleared by 
centrifugation and the supernatant incubated for eight hours with anti-FLAG M2 
agarose (Sigma), washed three times with BC300 with 0.1% NP-40 (Sigma) and 
eluted with BC150 (BC0 with 150mM KCl) with 0.1% NP-40 containing 0.3 mg/ml 
3xFLAG peptide (Sigma). The complex was then analyzed by silver staining or 
concentrated with an Amicon Ultra 10K centrifugal filter and sent for mass 
spectrometry analysis. 
 
 cDNAs were  cloned into pFASTBAC1 vectors either directly, or after 
modification to include an N-terminal FLAG epitope. Baculoviruses were 
generated according to the manufacturer’s instruction (Invitrogen). Sf9 cells were 
infected with the desired baculoviruses and incubated for 72 hours. The infected 
cells were collected and resuspended in BC300 with 0.1% NP-40 and sonicated 
for 2.5 minutes in a Diagenode bioruptor. Cell debris was removed by 
centrifugation and the supernatant incubated with M2 agarose beads (Sigma) for 
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four hours. The complex was then washed and eluted as described for the ING4 
complex purification. 
 The p208ML DNA template along with p300, NAP1 and the chromatin 
assembly factors ACF1, ISWI and TOPO1, as well as FLAG-tagged p53 and 
GST tagged p53 were purified as described (An, et al., 2004). Unmodified 
recombinant histones together with histones containing the semi-synthetic 
H3Kc4me3 (Simon, et al., 2007) were assembled into histone octamers and 
combined with the DNA template and incubated with chromatin assembly factors 
to assemble chromatin as described (An & Roeder, 2004). HeLa nucleosomes 
were purified from HeLa cell nuclear pellets as described (Owen-Hughes, et al., 
1999). 
 
6.4 Histone modification assays 
 HAT assays were carried out in 10mM HEPES (pH 7.9), 30mM KCl, 
2.5mM DTT, 0.25mM EDTA, 5mM sodium butyrate and 5mM MgCl2 with 2ul of 
0.5mM 3H acetyl-CoA or unlabeled acetyl-CoA added together with the HATs in a 
total volume of 31.5ul. For the assays on HeLa nucleosomes and free histones, 
4ul ING4C, 8ul JHIE or 8ul BHIE was added to 200ng of substrate and incubated 
with at 30’C for one hour (Fig 9A). For assays on chromatin, 50ng of p53 was 
incubated with 95ng of DNA assembled into chromatin for 20 minutes at 27’C, 
followed by addition of p300, ING4C, JHIE or BHIE and incubated for one hour at 
30’C. For the titration assay 10, 20, 40 or 80ng of ING4C, 5, 10, 20 or 40ng of 
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JHIE or 40 or 60ng of BHIE, as measured by the amount of HBO1 present in the 
complex were used (Fig 9D). For the time course, 10ng ING4C and 200ng p300 
were used (Fig 9E), while for the other chromatin HAT assays 200ng of p300, 
80ng of ING4C, 60ng JHIE and 60ng BHIE was used (Fig 9F, Fig 10C & 10D). 
For the assays examining p300 and ING4 complex HAT activity, 25, 50 or 100ng 
of p300, and 7.5, 15 or 30ng of JHIE or BHIE complex was used (Fig 12A & 
12C).. For the KMT/HAT assay 120ng ING4C, 70ng p300 and 50ng p53 was 
used and where indicated, SAM was added to a final concentration of 50µM SAM 
(Fig 13B). Samples were run on a 15% acrylamide gel and analyzed by 
immunoblot or autoradiography as indicated. 
 
 For the H3 peptide HAT assay, biotinylated H3 peptides with different K4 
methylation states were synthesized by the Rockefeller core facility and 
conjugated to streptavidin agarose beads (Thermo Scientific) by incubation of 25 
µg of peptide with 25 ul of beads for 3 hours at room temperature, followed by 
extensive washing with PBS (137mM NaCl, 2.7mM KCl, 10mM Na2HPO4 and 
1.8mM KH2PO4, pH 7.4) with 0.1% Triton-X (Sigma). 250ng of H3 peptide was 
incubated with 2ul of 0.5mM 3H acetyl-CoA and 8ul ING4C for one hour at 30’C, 
washed extensively with TBS (150mM NaCl, 2.5mM KCl, 25mM Tris-HCl, pH 8), 
and the cpm measured by scintillation (Fig 10A). 
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6.5 p53 coIP and in vitro binding assays 
 ~25x106 HCT 116 cells were treated with 0.5µM doxorubicin for 24 hours 
to activate p53, harvested, pelleted, then lysed by suspension in BC150 with 
0.1% NP-40 and sonication on ice. The suspension was cleared by centrifugation 
and precleared with Protein A sepharose (Amersham). 5ul of ING4 antibody or 
IgG control antibody was then added to the supernatant and incubated overnight 
at 4’C. Protein A sepharose was incubated with the supernatant for 4 hours at 
4’C, then extensively three times with BC300 with 0.1% NP-40. Samples were 
eluted from the beads with SDS sample buffer and analyzed by immunoblot. 
  
For the in vitro binding assays, 1µg GST-p53 or control GST protein was 
incubated with 400ng of indicated ING4 complex subunit/s in BC150 with 0.1% 
NP-40 for 2 hours at 4’C. Gluthathione 4B sepharose was subsequently 
incubated with the sample for 1 hour at 4’C, then washed five times with BC150 
with 0.1% NP-40. Samples were eluted with SDS sample buffer and analyzed by 
immunoblot.  
 
6.6 ChIPs 
 ChIP assays were performed as described (Lauberth, et al., 2013) with 5ul 
of antibodies and enrichment at three sites around the TSS of p21 measured by 
qPCR. ING4 and H3K9ac values were normalized to the values in untreated  
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Table 3. Primers used in ChIP qPCR assays. 
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cells. Primers used for the qPCR are listed in Table 3. The TSS and +507 
primers were adapted from Donner et al (Donner, et al., 2007) 
 
6.7 Transcription assays 
 In vitro transcription assays from chromatin templates were performed 
essentially as described (An & Roeder, 2004). Briefly, 40ng of DNA template 
assembled into chromatin was incubated with 50ng of p53 for 20 minutes at 27’C 
followed by addition of indicated HATs and acetyl-CoA and a further incubation at 
30’C for one hour. 5ul of HeLa nuclear extract was then incubated with the 
reaction for 15 minutes to allow PIC formation, followed by the addition of 
nucleotides and a further 60 minute incubation to allow transcription. For 
sequential modifications, p300 was incubated for 30 minutes, followed by 
incubation with the indicated complexes for one hour at 30’C. 
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